Oxygen-derived free radicals and myocardial reperfusion injury: An overview

Cardiovascular Drugs and Therapy

Volumn 5, Issue 2 Supplement, 1991, Pages 249-268

  Bolli, Roberto ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

calcium homeostasis; coronary reperfusion; electron paramagnetic resonance spectroscopy; lipid peroxidation; myocardial infarction; myocardial ischemia; oxygen free radicals; postischemic dysfunction; reperfusion arrhythmias; spin trapping

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ANTIOXIDANT; CATALASE; DEFEROXAMINE; DIMETHYLTHIOUREA; FREE RADICAL; OXIPURINOL; SUPEROXIDE DISMUTASE; TIOPRONIN;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; DOG; HEART ARRHYTHMIA; HEART CONTRACTION; ISCHEMIA; MONKEY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; TISSUE NECROSIS;

ANIMAL; ARRHYTHMIA; BIOMECHANICS; FREE RADICALS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXYGEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025760521     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/BF00054747     Document Type: Article

References (157)

1. Factors involved in salvaging ischemic myocardium. Effects of reperfusion of arterial blood
2. Myocardial consequences of reperfusion
3. Reperfusion-induced arrhythmias: Mechanisms and prevention
4. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart
5. Intracellular free calcium concentration measured by 19F NMR spectroscopy in intact ferret hearts
6. Cytosolic calcium transients from the beating mammalian heart
7. Calcium and its role in myocardial cell injury during ischemia and reperfusion
8. Reperfusion injury and its pharmacologic modification
9. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol
10. Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart
11. Reperfusion-induced arrhythmias and oxygen-derived free radicals: Studies with “anti-free radical” interventions and a free radical-generating system in the isolated perfused rat heart
12. Superoxide dismutase and the reduction of reperfusion-induced arrhythmias: In vivo dose-response studies in the rat
13. Reperfusion-induced arrhythmias: A study of the role of xanthine oxidase-derived free radicals in the rat heart
14. Free radicals and calcium: Simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart
15. Singlet oxygen-induced arrhythmias. Dose- and light-response studies for photoactivation of rose bengal in the rat heart
16. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs
17. Persistence of myocardial injury following brief periods of coronary occlusion
18. Coronary arterial reperfusion. III. Early and late effects on regional myocardial function and dimensions in conscious dogs
19. Depression of regional blood flow and wall thickening after brief coronary occlusions
20. Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs
21. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs: Comparison of 2- and 4-hour occlusions
22. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion
23. Sustained regional dysfunction produced by prolonged coronary stenosis: Gradual recovery after reperfusion
24. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastucture and microvascular damage
25. Time-course and determinants of recovery of function after reversible ischemia in conscious dogs
26. Prolonged abnormalities of left ventricular diastolic wall thinning in the “stunned” myocardium in conscious dogs: Time-course and relation to systolic function
27. Nonuniform transmural recovery of contractile function in the “stunned” myocardium
28. The stunned myocardium: Prolonged, postischemic ventricular dysfunction
29. Postischemic myocardial “stunning”: A clinically relevant phenomenon
30. Validation of a single crystal for measurement of transmural and epicardial thickening
31. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia
32. Superoxide dismutase plus catalase improve contractile function in the canine model of the “stunned” myocardium
33. Beneficial actions of superoxide dismutase and catalase in “stunned” myocardium of dogs
34. Free radicals do not cause myocardial stunning after four 5 minute coronary occlusions (abstract)
35. Effect of superoxide dismutase and catalase, given separately, on myocardial “stunning”
36. Effect of intracoronary superoxide dismutase on regional function in stunned myocardium
37. N-2-mercaptopropionyl glycine improves recovery of myocardial function following reversible regional ischemia
38. Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea
39. Attenuation of dysfunction in the postischemic “stunned” myocardium by dimenthylthiorea
40. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction
41. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart
42. Oxygen toxicity, oxygen radicals, transition metals and disease
43. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: Evidence that myocardial “stunning” is a manifestation of reperfusion injury
44. Myocardial alterations due to free-radical generation
45. Influence of exogenously generated oxidant species on myocardial function
46. O2 free radicalmediated myocardial and vascular dysfunction
47. Evidence for a pathogenetic role of xanthine oxidase in the “stunned” myocardium
48. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion
49. Beneficial effects of oxypurinol pretreatment in stunned, reperfused canine myocardium
50. Significance of xanthine oxidase in capillary endothelial cells
51. Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts
52. The activity of xanthine oxidase in hearts of pigs, guinea pigs, rats, and humans
53. Urate production by human heart
54. Absence of detectable xanthine oxidase in human myocardium
55. Lipoxygenase inhibitor nafazatrom fails to attenuate postischemic ventricular dysfunction
56. Influence of neutrophil depletion on myocardial function and flow after reversible ischemia
57. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury
58. Neutrophil depletion does not prevent myocardial dysfunction after brief coronary occlusion
59. F(ab′)2 fragments of anti-mol (904) monoclonal antibodies do not prevent myocardial stunning
60. Does reduction of leukocyte accumulation in reperfused myocardium affect stunning?
61. Free radicals and myocardial ischemia and reperfusion injury
62. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog
63. Alleviation of myocardial stunning by leukocyte and platelet depletion
64. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: A new approach to assessing the role of oxygen radicals in myocardial “stunning”
65. Demonstration of free radical generation in “stunned” myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone
66. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog
67. Conjugated dienes in ischemic and reperfused myocardium: An in vivo chemical signature of oxygen free radical mediated injury
68. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavening free radicals?
69. Antioxidant enzymes attenuate myocardial “stunning” in the conscious dog (abstract)
70. The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis
71. Oxygen- and carbon-centered free radical formation during carbon tetrachloride metabolism
72. Direct measurement of free radical generation following reperfusion of ischemic myocardium
73. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy
74. Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron spin resonance spectroscopy
75. Measurement of superoxide-derived free radicals in the reperfused heart
76. Effects of hydrogen peroxide on cardiac function and postischemic functional recovery in the isolated “working” rat heart
77. Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart
78. Quantitative identification of superoxide anion as a negative inotropic species
79. Effects of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricle: Implications for ischemia and reperfusion injury
80. Myocardial dysfunction and ultrastructural alterations mediated by oxygen metabolites
81. In vivo infusion of oxygen free radical substrates causes myocardial systolic, but not diastolic dysfunction
82. Protein damage and degradation by oxygen radicals. I. General aspects
83. Myocardial free-radical injury after cardioplegia
84. Alterations in cardiac sarcoplasmic reticulum calcium transport in the post-ischemic “stunned” myocardium
85. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum: Participation of the cyclooxygenase pathway
86. Differential sensitivity of canine cardiac sarcolemmal and microsomal enzymes to inhibition by free radical-induced lipid peroxidation
87. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles
88. O2 free radicals: Cause of ischemia-reperfusion injury to cardiac Na+−K+-ATPase
89. Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals
90. Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers
91. Free radical scavengers improve functional recovery of stunned myocardium in a model of surgical coronary revascularization
92. Oxygen radicals in cardiac surgery
93. Amelioration of postischemic stunning by deferoxamine-blood cardioplegia
94. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart
95. Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury
96. Oxygen free radical scavengers protect the arrested globally ischemic heart upon reperfusion
97. A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase
98. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts
99. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: Reduction by recombinant human superoxide dismutase administered at the time of reflow
100. Protection by superoxide dismutase and catalase in the isolated rat heart reperfused after prolonged cardioplegia: A combined study of metabolic, functional, and morphometric ultrastructural variables
101. Effect of human recombinant superoxide dismutase on canine myocardial infarction
102. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional myocardial function or myocardium at risk in conscious dogs
103. “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow
104. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function
105. Effect of verapamil on postischemic “stunned” myocardium: Importance of the timing of treatment
106. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine
107. Effect of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs
108. Effect of diltiazem and propranolol on left ventricular segmental relaxation in conscious dogs
109. Differential enhancement of postischemic segmental systolic thickening by diltiazem
110. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic “stunned” myocardium
111. Reversibly injured, postischemic canine myocardium retains normal contractile reserve
112. Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts
113. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts
114. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts
115. Transient acidosis by staged reperfusion prevents myocardial stunning (abstract)
116. Direct measurement of [Ca2+]i in early and late reperfused myocardium (abstract)
117. Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning?
118. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation
119. Recruitment of inotropic reserve in “stunned” myocardium by the cardiotonic agent AR-L 57
120. The oxygen paradox and the calcium paradox: Two facets of the same problem?
121. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH
122. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+−Na+ and Na+−Ca2+ exchange
123. Mechanisms of reoxygenation-induced calcium overload in cultured chick embryo heart cells
124. Oxygen-derived free radicals in postischemic tissue injury
125. Can superoxide dismutase alter myocardial infarct size?
126. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase
127. Xanthine oxidase as a source of free radical damage in myocardial ischemia
128. The independent effects of oxygen radical scavengers on canine infarct size: Reduction by superoxide dismutase but not catalase
129. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insights into the pathophysiology of reperfusion injury
130. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model
131. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion
132. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs
133. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion
134. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: Salvage or delay of myocyte necrosis?
135. Failure to reduce infarct size by intracoronary infusion of human superoxide dismutase at reperfusion in the pig heart: Immuno-histochemical and histological analysis (abstract)
136. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart
137. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs
138. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: A demonstration of myocardial salvage
139. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion
140. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart
141. Early treatment with deferoxamine limits myocardial ischemia/reperfusion injury
142. Deferoxamine, an iron chelator, reduces canine infarct size (abstract)
143. Failure of xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs
144. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs
145. Canine myocardial reperfusion injury: Protection by a free radical scavenger, N-2-mercaptopropionyl glycine
146. Intracoronary superoxide dismutase for the treatment of “reperfusion injury”. A blind randomized placebo-controlled trial in ischemic, reperfused porcine hearts
147. Oxypurinol and allopurinol reduce infarct size in reperfused dogs heart without pretreatment (abstract)
148. Limitation of myocardial infarct size by superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig
149. Protection afforded by allopurinol in the first 24 hours of occlusion is diminished after 48 hours
150. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog